• Consensus Rating: Hold
  • Consensus Price Target: $167.33
  • Forecasted Upside: 2.66 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 11 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$162.99
▲ +0.12 (0.07%)

This chart shows the closing price for LHCG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New LHC Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LHCG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LHCG

Analyst Price Target is $167.33
▲ +2.66% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for LHC Group in the last 3 months. The average price target is $167.33, with a high forecast of $185.00 and a low forecast of $150.00. The average price target represents a 2.66% upside from the last price of $162.99.

This chart shows the closing price for LHCG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 11 polled investment analysts is to hold stock in LHC Group. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 0 sell ratings
2/25/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/26/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 0 sell ratings
11/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 0 sell ratings
2/20/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 11 hold ratings
  • 0 sell ratings
5/21/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 11 hold ratings
  • 0 sell ratings
7/20/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 11 hold ratings
  • 0 sell ratings
8/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 11 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/25/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$190.00 ➝ $170.00Medium
4/12/2022BarclaysBoost TargetEqual Weight$154.00 ➝ $170.00Low
4/4/2022Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$172.00 ➝ $170.00Low
3/31/2022Truist FinancialDowngradeBuy ➝ HoldLow
3/30/2022StephensDowngradeOverweight ➝ Equal WeightLow
3/30/2022BenchmarkDowngradeBuy ➝ HoldMedium
3/30/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$181.00 ➝ $170.00Medium
3/29/2022William BlairDowngradeOutperform ➝ Market PerformLow
3/10/2022Truist FinancialBoost TargetBuy$175.00 ➝ $185.00High
2/28/2022Credit Suisse GroupLower TargetOutperform$184.00 ➝ $181.00Medium
2/24/2022BenchmarkLower TargetBuy$190.00 ➝ $170.00High
11/10/2021SVB LeerinkBoost TargetMarket Perform$149.00 ➝ $151.00Medium
11/5/2021BarclaysLower TargetEqual Weight$207.00 ➝ $171.00Low
11/5/2021Credit Suisse GroupLower TargetOutperform$191.00 ➝ $184.00High
11/5/2021Royal Bank of CanadaLower TargetOutperform$192.00 ➝ $180.00High
10/26/2021CowenDowngradeOutperform ➝ Market Perform$209.00 ➝ $150.00High
10/19/2021Royal Bank of CanadaLower TargetOutperform$253.00 ➝ $192.00High
10/19/2021SVB LeerinkLower TargetMarket Perform$173.00 ➝ $149.00High
10/19/2021Credit Suisse GroupLower TargetOutperform$252.00 ➝ $191.00High
10/19/2021Deutsche Bank AktiengesellschaftLower TargetBuy$245.00 ➝ $190.00High
10/18/2021BenchmarkLower TargetBuy$260.00 ➝ $210.00High
10/13/2021Truist FinancialLower TargetBuy$240.00 ➝ $185.00Low
9/27/2021SVB LeerinkInitiated CoverageMarket Perform$173.00Low
9/23/2021UBS GroupInitiated CoverageNeutral$170.00Low
9/22/2021Deutsche Bank AktiengesellschaftLower TargetBuy$260.00 ➝ $245.00Low
9/9/2021CowenInitiated CoverageOutperform$209.00Medium
8/19/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy$260.00Low
8/12/2021BarclaysDowngradeOverweight ➝ Equal Weight$245.00 ➝ $207.00Low
8/10/2021Credit Suisse GroupLower TargetOutperform$255.00 ➝ $252.00Medium
7/9/2021BenchmarkBoost TargetPositive ➝ Buy$250.00 ➝ $260.00Medium
2/8/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$240.00 ➝ $260.00Medium
1/25/2021Credit Suisse GroupInitiated CoverageOutperform$255.00Low
1/5/2021Truist FinancialBoost Target$245.00 ➝ $260.00N/A
11/17/2020OppenheimerReiterated RatingBuyLow
11/5/2020OppenheimerBoost TargetOutperform$245.00 ➝ $250.00High
10/19/2020OppenheimerBoost TargetOutperform$233.00 ➝ $245.00Medium
8/12/2020UBS GroupDowngradeBuy ➝ Neutral$170.00 ➝ $210.00Low
8/11/2020StephensBoost TargetOverweight$200.00 ➝ $225.00High
7/9/2020SunTrust BanksBoost TargetBuy$200.00 ➝ $220.00Low
7/1/2020BenchmarkBoost TargetBuy$160.00 ➝ $190.00Medium
6/3/2020Deutsche Bank AktiengesellschaftBoost TargetPositive ➝ Buy$160.00 ➝ $165.00High
5/21/2020SunTrust BanksBoost TargetBuy$160.00 ➝ $200.00Medium
5/14/2020UBS GroupLower TargetBuy$179.00 ➝ $170.00Low
3/20/2020BenchmarkBoost TargetBuy$144.00 ➝ $160.00High
3/4/2020Royal Bank of CanadaReiterated RatingBuy$180.00Medium
3/2/2020StephensLower TargetOverweight$161.00 ➝ $150.00Medium
2/28/2020Robert W. BairdLower TargetNeutral$170.00 ➝ $150.00High
12/6/2019SunTrust BanksBoost TargetBuy$145.00 ➝ $160.00Low
11/7/2019William BlairReiterated RatingOutperformLow
10/21/2019StephensInitiated CoverageOverweight$132.00Low
9/23/2019UBS GroupBoost TargetBuy$133.00 ➝ $136.00Low
9/16/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$145.00Medium
8/9/2019Royal Bank of CanadaSet TargetBuy$135.00Medium
8/9/2019OppenheimerBoost TargetOutperform$125.00 ➝ $146.00Medium
8/9/2019BarclaysBoost TargetEqual Weight$113.00 ➝ $120.00Medium
5/13/2019Royal Bank of CanadaBoost TargetOutperform$130.00Low
5/12/2019BarclaysReiterated RatingNeutral ➝ HoldLow
5/10/2019UBS GroupSet TargetBuy$133.00Low
5/9/2019Jefferies Financial GroupBoost TargetBuy$125.00 ➝ $130.00High
3/21/2019BarclaysBoost TargetEqual Weight ➝ Equal Weight$95.00 ➝ $104.00Low
3/4/2019Robert W. BairdBoost TargetNeutral ➝ Neutral$98.00 ➝ $120.00Low
3/1/2019SunTrust BanksBoost TargetBuy$130.00Low
3/1/2019Craig HallumBoost TargetHold$93.00 ➝ $114.00Low
12/14/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$105.00High
11/15/2018UBS GroupInitiated CoverageBuy ➝ Buy$109.00High
11/2/2018Robert W. BairdBoost TargetNeutral ➝ Neutral$95.00 ➝ $98.00Low
11/1/2018William BlairReiterated RatingBuyHigh
10/26/2018Craig HallumDowngradeBuy ➝ Hold$99.00 ➝ $92.00High
9/18/2018Bank of AmericaSet TargetBuy$119.00Low
9/13/2018SunTrust BanksBoost TargetBuy$115.00Low
9/12/2018Cantor FitzgeraldInitiated CoverageOverweight$117.00Low
8/3/2018Royal Bank of CanadaBoost TargetSector Perform$101.00Medium
8/3/2018Jefferies Financial GroupBoost TargetBuy$120.00Medium
8/2/2018BenchmarkSet TargetBuy$110.00High
8/2/2018OppenheimerBoost TargetOutperform$85.00 ➝ $110.00High
5/6/2018William BlairReiterated RatingBuyMedium
4/4/2018Craig HallumBoost TargetBuy$70.00 ➝ $80.00High
4/4/2018Jefferies Financial GroupReiterated RatingBuy ➝ Buy$84.00High
3/2/2018StephensSet TargetBuy$74.00Low
12/7/2017OppenheimerReiterated RatingBuy$85.00Low
11/28/2017Robert W. BairdSet TargetHold$71.00Low
11/21/2017William BlairReiterated RatingOutperformN/A
11/17/2017OppenheimerBoost TargetOutperform$80.00 ➝ $85.00N/A
11/10/2017Robert W. BairdReiterated RatingHold$69.00N/A
11/7/2017OppenheimerBoost TargetOutperform$68.00 ➝ $80.00N/A
11/7/2017Craig HallumReiterated RatingBuy$67.00 ➝ $80.00N/A
11/7/2017Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$70.00 ➝ $81.00N/A
11/7/2017Jefferies Financial GroupBoost TargetHold ➝ Buy$68.00 ➝ $83.00N/A
11/3/2017SunTrust BanksReiterated RatingBuy$75.00N/A
9/12/2017Robert W. BairdReiterated RatingHold$63.00Low
9/6/2017Royal Bank of CanadaReiterated RatingBuy$70.00Low
8/21/2017Bank of AmericaInitiated CoverageBuy ➝ Buy$76.00Low
(Data available from 8/19/2017 forward)

News Sentiment Rating

-0.01 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/21/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/20/2022
  • 1 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/22/2022
  • 3 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/21/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/21/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/20/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/20/2022
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/19/2022

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
LHC Group logo
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. As of December 31, 2021, it operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
Read More

Today's Range

Now: $162.99
Low: $162.50
High: $163.38

50 Day Range

MA: $160.35
Low: $154.43
High: $164.06

52 Week Range

Now: $162.99
Low: $108.42
High: $188.59

Volume

98,887 shs

Average Volume

458,087 shs

Market Capitalization

$5.06 billion

P/E Ratio

68.77

Dividend Yield

N/A

Beta

0.48

Frequently Asked Questions

What sell-side analysts currently cover shares of LHC Group?

The following Wall Street sell-side analysts have issued research reports on LHC Group in the last year: Barclays PLC, Benchmark Co., Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Royal Bank of Canada, Stephens, StockNews.com, SVB Leerink LLC, TheStreet, Truist Financial Co., UBS Group AG, and William Blair.
View the latest analyst ratings for LHCG.

What is the current price target for LHC Group?

9 Wall Street analysts have set twelve-month price targets for LHC Group in the last year. Their average twelve-month price target is $167.33, suggesting a possible upside of 2.7%. Truist Financial Co. has the highest price target set, predicting LHCG will reach $185.00 in the next twelve months. Cowen Inc has the lowest price target set, forecasting a price of $150.00 for LHC Group in the next year.
View the latest price targets for LHCG.

What is the current consensus analyst rating for LHC Group?

LHC Group currently has 11 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in LHCG, but not buy more shares or sell existing shares.
View the latest ratings for LHCG.

What other companies compete with LHC Group?

How do I contact LHC Group's investor relations team?

LHC Group's physical mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider's listed phone number is (337) 233-1307 and its investor relations email address is [email protected] The official website for LHC Group is www.lhcgroup.com. Learn More about contacing LHC Group investor relations.